Kiniksa Pharmaceuticals International Insider Sold Shares Worth $357,680, According to a Recent SEC Filing
US Manufacturing Index Rises To 43, Highest Since 2020
Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference
J.P. Morgan Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $40
Kiniksa Pharmaceuticals International, Plc Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Kiniksa Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group